Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China-connected Origin Technologies Bids $1.6 Billion for Affymetrix

publication date: Mar 23, 2016
Origin Technologies, a US company with deep China connections, has raised its bid to acquire Affymetrix, a US microarray company, to $17 per share. Affymetrix responded by postponing a shareholder vote, scheduled for tomorrow, on a $14 per share takeover offer from scientific instruments company Thermo Fisher Scientific. Origin is a shell that is tied to Centrillion Technologies, a California genomics company with manufacturing in China and Taiwan. Origin's management includes Wei Zhou, who is also president and CEO of Centrillion and was formerly a VP at Affymetrix. More details....

Stock Symbols: (NSDQ: AFFX) (NYSE: TMO)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital